| P50 | author | Cyril Gay | Q56932696 |
| | Bryan Charleston | Q61162596 |
| P2093 | author name string | L L Rodriguez | |
| | T J D Knight-Jones | |
| | K J Sumption | |
| | L Robinson | |
| | W Vosloo | |
| P2860 | cites work | Bovine type III interferon significantly delays and reduces the severity of foot-and-mouth disease in cattle | Q34149287 |
| | Expression of porcine fusion protein IRF7/3(5D) efficiently controls foot-and-mouth disease virus replication. | Q34261893 |
| | Quantification of transmission of foot-and-mouth disease virus caused by an environment contaminated with secretions and excretions from infected calves | Q35497571 |
| | Transgenic shRNA pigs reduce susceptibility to foot and mouth disease virus infection | Q35852460 |
| | Antivirals and antiviral strategies | Q35889586 |
| | Virus-resistant pigs might help to stem next outbreak | Q35899473 |
| | Venezuelan equine encephalitis replicon particles can induce rapid protection against foot-and-mouth disease virus | Q36827455 |
| | Nationwide surveillance for pathogenic microorganisms in groundwater near carcass burials constructed in South Korea in 2010. | Q37434917 |
| | Multiple microRNAs targeted to internal ribosome entry site against foot-and-mouth disease virus infection in vitro and in vivo | Q37520833 |
| | Investigation of disinfectants for foot-and-mouth disease in the Republic of Korea | Q38133708 |
| | A thiazepino[4,5-a]benzimidazole derivative hampers the RNA replication of Eurasian serotypes of foot-and-mouth disease virus | Q38935702 |
| | Cattle remain immunocompetent during the acute phase of foot-and-mouth disease virus infection. | Q38936078 |
| | Induction of protection against foot-and-mouth disease virus in cell culture and transgenic suckling mice by miRNA targeting integrin αv receptor | Q38976092 |
| | Swine interferon-induced transmembrane protein, sIFITM3, inhibits foot-and-mouth disease virus infection in vitro and in vivo | Q38980086 |
| | A recombinant adenovirus bicistronically expressing porcine interferon-α and interferon-γ enhances antiviral effects against foot-and-mouth disease virus | Q39028359 |
| | Application of a cell-based protease assay for testing inhibitors of picornavirus 3C proteases | Q39037067 |
| | Biosecurity aspects and pathogen inactivation in acidified high risk animal by-products | Q39364143 |
| | Virus inactivation by salt (NaCl) and phosphate supplemented salt in a 3D collagen matrix model for natural sausage casings. | Q39532272 |
| | Porcine Type I Interferon Rapidly Protects Swine Against Challenge with Multiple Serotypes of Foot-and-Mouth Disease Virus | Q39651097 |
| | Protection against Rift Valley fever virus infection in mice upon administration of interferon-inducing RNA transcripts from the FMDV genome | Q40202028 |
| | Virus survival in slurry: analysis of the stability of foot-and-mouth disease, classical swine fever, bovine viral diarrhoea and swine influenza viruses | Q40299977 |
| | Disinfection of foot-and-mouth disease and African swine fever viruses with citric acid and sodium hypochlorite on birch wood carriers | Q40304795 |
| | Chemical disinfection of high-consequence transboundary animal disease viruses on nonporous surfaces | Q40316924 |
| | High IFN-alpha responses associated with depletion of lymphocytes and natural IFN-producing cells during classical swine fever. | Q40479007 |
| | Adenovirus-mediated type I interferon expression delays and reduces disease signs in cattle challenged with foot-and-mouth disease virus. | Q40631271 |
| | A Refined Guinea Pig Model of Foot-and-Mouth Disease Virus Infection for Assessing the Efficacy of Antiviral Compounds. | Q42197160 |
| | Type III interferon protects swine against foot-and-mouth disease. | Q42221115 |
| | Novel antiviral therapeutics to control foot-and-mouth disease. | Q43976690 |
| | Proof of concept for the inhibition of foot-and-mouth disease virus replication by the anti-viral drug 2'-C-methylcytidine in severe combined immunodeficient mice. | Q45214942 |
| | Foot-and-mouth disease virus causes a decrease in spleen dendritic cells and the early release of IFN-α in the plasma of mice. Differences between infectious and inactivated virus | Q45359198 |
| | Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha. | Q45419096 |
| P921 | main subject | disinfectant | Q73984 |
| | foot-and-mouth disease | Q152401 |
| | disinfection | Q24887418 |
| P304 | page(s) | 49-55 | |
| P577 | publication date | 2016-06-01 | |
| P1433 | published in | Transboundary and Emerging Diseases | Q15753253 |
| P1476 | title | Global Foot-and-Mouth Disease Research Update and Gap Analysis: 5 - Biotherapeutics and Disinfectants | |
| P478 | volume | 63 Suppl 1 | |